Integrated Filing — IndAS



General information about company

Scrip Code 524200
NSE Symbol VINATIORGA
MSEI Symbol NOTLISTED
ISIN INE410B01037
Name of company VINATI ORGANICS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 05-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Specialty Chemicals
Start date and time of board meeting 12-05-2026   12:15:00
End date and time of board meeting 12-05-2026   14:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 31-01-2026
Indicate Company website link for updated RPT policy of the Company https://vinatiorganics.com/wp-content/uploads/2021/05/Policy-on-Related-Party-Transaction-2.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 61,055.00 2,22,822.00
Other income 2,050.00 5,257.00
Total income 63,105.00 2,28,079.00
2 Expenses
(a) Cost of materials consumed 26,452.00 1,06,653.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 2,863.00 (2,779.00)
(d) Employee benefit expense 3,887.00 16,381.00
(e) Finance costs 2.00 41.00
(f) Depreciation, depletion and amortisation expense 2,491.00 9,199.00
(f) Other Expenses
1 Power & Fuel Expenses 3,770.00 14,577.00
2 Other Expenditure 5,771.00 19,153.00
Total other expenses 9,541.00 33,730.00
Total expenses 45,236.00 1,63,225.00
3 Total profit before exceptional items and tax 17,869.00 64,854.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 17,869.00 64,854.00
6 Tax expense
7 Current tax 2,426.00 12,909.00
8 Deferred tax 1,692.00 3,167.00
9 Total tax expenses 4,118.00 16,076.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 13,751.00 48,778.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 13,751.00 48,778.00
17 Other comprehensive income net of taxes 36.00 (15.00)
18 Total Comprehensive Income for the period 13,787.00 48,763.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,037.00 1,037.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 3,20,624.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 13.26 47.05
Diluted earnings (loss) per share from continuing operations 13.26 47.05
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 13.26 47.05
Diluted earnings (loss) per share from continuing and discontinued operations 13.26 47.05
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above results were reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting held on 12th May, 2026. The Statutory Auditors have expressed unmodified opinion on said results. 2. The Company is engaged in Manufacturing of Chemicals. This in the context of Ind AS 108 operating segment are considered to constitute one single primary segment. 3.The figures for the Quarter ended 31st March, 2026 and 31st March, 2025 are the balancing figures between the audited figures in respect of the full financial year and the year-to-date figures upto the third Quarter of the Financial year. 4. This statement has been prepared in accordance with companies ( Indian Accounting Standards ) Rules 2015 (Ind AS), prescribed u/s 133 of the Companies Act,2013 and other recognised accounting practices and policies to the extent applicable. 5. The Boards of Directors recommended dividend of Rs. 8.50 for the Financial Year 2025-2026, The payment is subject to approval of the shareholders in the ensuing Annual General Meeting. 6. Previous period/year figures are regrouped, rearranged, wherever necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,61,159.00
Capital work-in-progress 12,638.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 21.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 74,699.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 669.00
Total of other non-current financial assets 669.00
Total non-current financial assets 75,368.00
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 2,227.00
Total of other non-current assets 2,227.00
Total non-current assets 2,51,413.00
2 Current assets
Inventories 28,232.00
Current financial asset
Current investments 19,045.00
Trade receivables, current 53,221.00
Cash and cash equivalents 256.00
Bank balance other than cash and cash equivalents 229.00
Loans, current 12.00
Other current financial assets
Total of other current financial assets 4,739.00
Total current financial assets 77,502.00
Current tax assets (net) 1,804.00
Other current assets
1 Other current assets 3,186.00
Total of other current assets 3,186.00
Total current assets 1,10,724.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 3,62,137.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,037.00
Other equity 3,20,624.00
Total equity attributable to owners of parent 3,21,661.00
Non controlling interest
Total equity 3,21,661.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 833.00
Total of other non-current financial liabilities 833.00
Total non-current financial liabilities 833.00
Provisions, non-current 0.00
Deferred tax liabilities (net) 18,571.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 19,404.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 637.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 10,816.00
Total Trade payable 11,453.00
Other current financial liabilities
1 Other current financial liabilities 2,364.00
Total of other current financial liabilities 2,364.00
Total current financial liabilities 13,817.00
Other current liabilities 6,291.00
1 Other current liabilities 6,291.00
Total of other current liabilities 6,291.00
Provisions, current 964.00
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 21,072.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 40,476.00
Total equity and liabilites 3,62,137.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (47.00) 20.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 11.00 (5.00)
5 Total Other comprehensive income 36.00 (15.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 64,854.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 41.00
Adjustments for decrease (increase) in inventories (6,554.00)
Adjustments for decrease (increase) in trade receivables, current 7,678.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 5,569.00
Adjustments for decrease (increase) in other non-current assets (140.00)
Adjustments for other financial assets, non-current (12.00)
Adjustments for other financial assets, current (146.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,703.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 646.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 9,199.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 40.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 398.00
Adjustments for other financial liabilities, non-current 142.00
Adjustments for unrealised foreign exchange losses gains (1,619.00)
Adjustments for dividend income 0.00
Adjustments for interest income 14.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (935.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (7.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 11,583.00
Net cash flows from (used in) operations 76,437.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 13,595.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 62,842.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 20,399.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 19,045.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 19.00
Purchase of property, plant and equipment 13,713.00
Proceeds from sales of investment property 4,524.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties (2.00)
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 15.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 116.00
Net cash flows from (used in) investing activities (48,485.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 6,262.00
Payments of lease liabilities 0.00
Dividends paid 7,792.00
Interest paid 41.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (13.00)
Net cash flows from (used in) financing activities (14,108.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 249.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 249.00
Cash and cash equivalents cash flow statement at beginning of period 7.00
Cash and cash equivalents cash flow statement at end of period 256.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M M NISSIM & CO LLP Yes 31-03-2028


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Vinati Organics Limited Viral Alkalis Limited Enterprise owned or significantly influenced by any Key Management Personnel or their Relatives Sale of goods or services 10.00 Approved 0.00 31-01-2025 1.00 0.00 0.00
2 Vinati Organics Limited Viral Alkalis Limited Enterprise owned or significantly influenced by any Key Management Personnel or their Relatives Purchase of goods or services 1,500.00 Approved 0.00 31-01-2025 11.00 0.00 0.00
3 Vinati Organics Limited Viral Alkalis Limited Enterprise owned or significantly influenced by any Key Management Personnel or their Relatives Any other transaction Sales of Rodtep License 1.00 Approved 0.00 31-01-2025 1.00 0.00 0.00
4 Vinati Organics Limited Viral Alkalis Limited Enterprise owned or significantly influenced by any Key Management Personnel or their Relatives Any other transaction Rent on Immovable Property 10.00 Approved 0.00 31-01-2025 3.00 0.00 0.00
5 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Share Application money (Converted into equity share capital ₹ 259.63) 25,000.00 Approved 0.00 31-01-2025 2,274.00 1,422.00 586.00
6 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Sale of goods or services 300.00 Approved 0.00 31-01-2025 33.00 216.00 0.00
7 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Sale of Rodtep Licence 100.00 Approved 0.00 31-01-2025 0.00 12.00 0.00
8 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Purchase of goods or services 600.00 Approved 0.00 31-01-2025 510.00 29.00 0.00
9 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Rent on Immovable Property 5.00 Approved 0.00 31-01-2025 0.00 0.00 0.00
10 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Job work Charges for coal crushing paid to VOPL 200.00 Approved 0.00 31-01-2025 184.00 10.00 0.00
11 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Sales - SAP HANA 25.00 Approved 0.00 31-01-2025 18.00 0.00 0.00
12 Vinati Organics Limited Veeral Organics Private Limited Wholly Owned Subsidary Any other transaction Sales - Others 3.00 Approved 0.00 31-01-2025 3.00 0.00 0.00
13 Vinati Organics Limited Vinati Organics USA INC Wholly Owned Subsidary Any other transaction Subscription to Equity Share Capital 1.00 Approved 0.00 31-01-2025 0.00 0.00 0.00
14 Vinati Organics Limited Vinati Organics USA INC Wholly Owned Subsidary Any other transaction Management Services Provided to VOL USA Inc 9.00 Approved 0.00 31-01-2025 9.00 0.00 0.00
15 Vinati Organics Limited Vinati Organics USA INC Wholly Owned Subsidary Sale of goods or services 2,000.00 Approved 0.00 31-01-2025 1,708.00 0.00 0.00
16 Vinati Organics Limited Mr. Vinod Saraf (Chairman) Key Managerial Personal Remuneration 311.00 Approved 0.00 31-01-2025 155.00 0.00 0.00
17 Vinati Organics Limited Ms. Vinati Saraf Mutreja (MD & CEO) Key Managerial Personal Remuneration 2,106.00 Approved 0.00 31-01-2025 1,053.00 0.00 0.00
18 Vinati Organics Limited Ms. Viral Saraf Mittal (Director-CSR) Key Managerial Personal Remuneration 142.00 Approved 0.00 31-01-2025 71.00 0.00 0.00
19 Vinati Organics Limited Mr. Amit Thanawala (Whole Time Director) Key Managerial Personal Remuneration 87.00 Approved 0.00 31-01-2025 87.00 0.00 0.00
20 Vinati Organics Limited Mr. N. K. Goyal (CFO) up to 05.11.2025 Key Managerial Personal Remuneration 76.00 Approved 0.00 31-01-2025 11.00 0.00 0.00
21 Vinati Organics Limited Mr. Gulshan Kumar Sakhuja (CFO) from 06.11.2025 onward Key Managerial Personal Remuneration 37.00 Approved 0.00 31-01-2025 37.00 0.00 0.00
22 Vinati Organics Limited Mr. Milind Wagh (CS) Key Managerial Personal Remuneration 52.00 Approved 0.00 31-01-2025 26.00 0.00 0.00
23 Vinati Organics Limited Mrs. Kavita Vinod Saraf Foundation Other Related Party Any other transaction CSR Contribution 113.00 Approved 0.00 31-01-2025 113.00 0.00 0.00
Total value of transaction during the reporting period 6,308.00





Format for Disclosing Outstanding Default on Loans and Debt Securities

Amount in (Lakhs)

<
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0.00
B Of the total amount outstanding, amount of default as on date 0.00
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0.00